Texas Childrens Cancer and Hematology Centers Texas Childrens Hospital Houston

Texas Childrens Cancer and Hematology Centers Texas Childrens Hospital Houston

SEARCH FILTERS
Time filter
Source Type

Flores R.J.,Baylor College of Medicine | Kelly A.J.,Baylor College of Medicine | Li Y.,Baylor College of Medicine | Chen X.,Baylor College of Medicine | And 5 more authors.
Pediatric Blood and Cancer | Year: 2017

Background: Osteosarcoma (OS) is the most common pediatric bone cancer. Despite advances in treatment regimens, the survival rate remains 60-70%. There is an urgent need to identify prognostic biomarkers, so that targeted therapies can be developed to improve the outcome. Procedure: Our laboratory has previously identified that circulating serum amyloid A (SAA) and CXC chemokine ligand 4 (CXCL4) are upregulated in patients with OS. In this study, we tested if they could be used as prognostic biomarkers. We used enzyme-linked immunosorbent assays to measure their concentrations in serum samples (n = 233) and immunohistochemistry to examine their expressions in primary tumors (n = 37). Prognostic significance of the serum concentrations and tumor expressions of the biomarkers was then evaluated. Results: Patients with "high SAA" and "low CXCL4" circulating levels at diagnosis significantly correlated with a worse outcome (HR = 1.68, P = 0.014), which was independent of the metastatic status. These patients also exhibited a significantly higher rate of poor histologic response to chemotherapy. Furthermore, low tumor expression of CXCL4 correlated with poor survival (HR = 3.57, P = 0.005). Conclusions: Our results demonstrate that circulating SAA and CXCL4 may serve as prognostic biomarkers in OS. Targeting CXCL4 has been reported, suggesting that it may be exploited as a therapeutic target in OS. © 2017 Wiley Periodicals, Inc.

Loading Texas Childrens Cancer and Hematology Centers Texas Childrens Hospital Houston collaborators
Loading Texas Childrens Cancer and Hematology Centers Texas Childrens Hospital Houston collaborators